The association between hydroxychloroquine treat- ment and cardiovascular morbidity among rheumatoid arthritis patients. 704. Sharma TS, Wasko MCM, Tang X, Vedamurthy D, Yan X, Cote J, Bili A. Hydroxychloroquine use is associated with decreased incident car- diovascular events in rheumatoid arthritis patients. J Am Heart Assoc. 705. Varona JF, Guerra JM, Bermejo F, Molina JA, Gomez de la C mara A. Causes of ischemic stroke in young adults, and evolution of the etio- logical diagnosis over the long term. Eur Neurol. 2007;57:212 218. doi: 706. Emmi G, Silvestri E, Squatrito D, Amedei A, Niccolai E, D Elios MM, Della Bella C, Grassi A, Becatti M, Fiorillo C, et al. Thrombosis in vas- culitis: from pathogenesis to treatment. Thromb J. 2015;13:15. doi: 707. Weyand CM, Goronzy JJ. Immune mechanisms in medium and large-vessel vasculitis. Nat Rev Rheumatol. 2013;9:731 740. doi: 708. Stamatis P. Giant cell arteritis versus Takayasu arteritis: an update. Mediterr J Rheumatol. 2020;31:174 182. doi: 10.31138/mjr.31.2.174 709. Hellmich B, Agueda A, Monti S, Buttgereit F, de Boysson H, Brouwer E, Cassie R, Cid MC, Dasgupta B, Dejaco C, et al. 2018 Update of the EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis. 2020;79:19 30. doi: 10.1136/annrheumdis-2019-215672 710. Gutierrez J, Ortiz G. HIV/AIDS patients with HIV vasculopathy and VZV vasculitis: a case series. Clin Neuroradiol. 2011;21:145 151. doi: 711. Lanthier S, Armstrong D, Domi T, deVeber G. Post-varicella arteriopathy of childhood: natural history of vascular stenosis. Neurology. 2005;64:660 712. Nagel MA, Forghani B, Mahalingam R, Wellish MC, Cohrs RJ, Russman AN, Katzan I, Lin R, Gardner CJ, Gilden DH. The value of detecting CLINICAL STATEMENTS AND GUIDELINES Kleindorfer anti-VZV IgG antibody in CSF to diagnose VZV vasculopathy. Neurology. 713. 